每年世界上许多人感染流感,病人出现许多烦恼的症状。作者研究了吸入性抗病毒药——Zanamivir治疗流感的效果及安全性。采用随机双盲对照试验方法,选择居住在澳大利亚、南非、新西兰的流感患者455人,年龄12岁以上,出现流感样症状36小时以内。随机分为两组。455人中321例(71％)是通过实验确诊的流感,其中214例(67％)为甲型(主要是H_3N_2),104例 Every year many people in the world are infected with the flu and the patient shows many troubles. The authors studied the efficacy and safety of inhaled antivirals - Yanamivir in the treatment of influenza. A randomized, double-blind, controlled trial of 455 influenza patients living in Australia, South Africa, and New Zealand, aged 12 years or older, developed flu-like symptoms within 36 hours. Randomly divided into two groups. Of the 455 patients, 321 (71%) were confirmed by the experiment, of which 214 (67%) were type A (mainly H_3N_2) and 104